Clinical Trial

Role of PCGEM1 in Breast Cancer

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 1, 2026 (before its estimated July 5, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study examines certain molecular markers in breast cancer using blood and tissue samples from routine diagnostic biopsies. No extra procedures will be performed on patients. The goal is to improve understanding of disease mechanisms and identify potential targets for treatment
Trial Details
NCT Number NCT07562789
Lead Sponsor Assiut University
Conditions Breast Cancer
Enrollment 90 participants
Start Date 2026-05-05
Primary Completion 2026-07-05 (estimated)
Study Completion 2026-08-06 (estimated)
Updated on ClinicalTrials.gov 2026-05-01